$1.41 Billion is the total value of Jasper Ridge Partners, L.P.'s 86 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 60.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
VWO | Sell | VANGUARD INTL EQUITY INDEX Fftse emr mkt etf | $62,074,000 | -39.2% | 1,897,695 | -38.5% | 4.40% | -42.3% |
IWD | Sell | ISHARES TRrus 1000 val etf | $19,345,000 | -18.7% | 197,680 | -22.5% | 1.37% | -22.8% |
EFG | Sell | ISHARES TReafe grwth etf | $3,988,000 | -3.2% | 59,403 | -8.0% | 0.28% | -7.8% |
NFLX | Sell | NETFLIX INC | $984,000 | -31.2% | 8,602 | -37.9% | 0.07% | -34.6% |
SCTY | Sell | SOLARCITY CORP | $562,000 | +17.8% | 11,025 | -1.4% | 0.04% | +11.1% |
IWO | Sell | ISHARES TRrus 2000 grw etf | $454,000 | -67.8% | 3,258 | -69.0% | 0.03% | -69.5% |
CVT | Sell | CVENT INC | $387,000 | -50.4% | 11,077 | -52.2% | 0.03% | -53.4% |
FB | Sell | FACEBOOK INCcl a | $317,000 | -58.5% | 3,030 | -64.3% | 0.02% | -61.4% |
SRNE | Exit | SORRENTO THERAPEUTICS INC | $0 | – | -7,288 | -100.0% | -0.01% | – |
CNAT | Exit | CONATUS PHARMACEUTICALS | $0 | – | -21,332 | -100.0% | -0.01% | – |
CRTO | Exit | CRITEO S Aspons ads | $0 | – | -7,166 | -100.0% | -0.02% | – |
CRM | Exit | SALESFORCE COM INC | $0 | – | -4,931 | -100.0% | -0.03% | – |
LMOS | Exit | LUMOS NETWORKS CORP | $0 | – | -34,498 | -100.0% | -0.03% | – |
CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -4,592 | -100.0% | -0.03% | – |
ZFGN | Exit | ZAFGEN INC | $0 | – | -16,841 | -100.0% | -0.04% | – |
AWAY | Exit | HOMEAWAY INC | $0 | – | -39,650 | -100.0% | -0.08% | – |
TWTR | Exit | TWITTER INC | $0 | – | -61,618 | -100.0% | -0.12% | – |
JD | Exit | JD COM INCspon adr cl a | $0 | – | -68,848 | -100.0% | -0.13% | – |
IVW | Exit | ISHARES TRs&p 500 grwt etf | $0 | – | -34,688 | -100.0% | -0.28% | – |
GOOG | Exit | GOOGLE INCcl c | $0 | – | -6,422 | -100.0% | -0.29% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2016-05-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES TR | 42 | Q3 2023 | 36.1% |
VANGUARD INTL EQUITY INDEX F | 42 | Q3 2023 | 17.6% |
ISHARES TR | 42 | Q3 2023 | 27.4% |
ISHARES TR | 42 | Q3 2023 | 10.8% |
NIKE INC | 42 | Q3 2023 | 18.8% |
ISHARES TR | 42 | Q3 2023 | 7.9% |
SPDR S&P 500 ETF TR | 42 | Q3 2023 | 3.7% |
ISHARES TR | 42 | Q3 2023 | 1.0% |
ISHARES TR | 42 | Q3 2023 | 2.6% |
ISHARES TR | 42 | Q3 2023 | 1.0% |
View Jasper Ridge Partners, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
R1 RCM INC. | May 03, 2018 | 332,835 | 3.0% |
Accretive Health, Inc. | December 19, 2011 | 8,101,774 | 8.2% |
NIKE INC | July 06, 2011 | 7,538,207 | 2.0% |
View Jasper Ridge Partners, L.P.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-15 |
13F-HR | 2022-11-14 |
13F-HR/A | 2022-08-15 |
13F-HR | 2022-08-15 |
13F-HR/A | 2022-08-12 |
View Jasper Ridge Partners, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.